Kezar Life Sciences Inc. (KZR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kezar Life Sciences Inc.

    NASDAQ: KZR · Real-Time Price · USD
    4.04
    0.02 (0.50%)
    At close: Sep 10, 2025, 11:18 AM

    Kezar Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 7M n/a n/a
    Cost of Revenue
    		 1.04M 1.07M 1.02M 1.51M
    Gross Profit
    		 -1.04M 5.93M -1.02M -1.51M
    Operating Income
    		 -90.61M -105.24M -71.16M -54.66M
    Interest Income
    		 8.46M 11.1M 4.11M 188K
    Pretax Income
    		 -83.74M -101.87M -68.24M -54.63M
    Net Income
    		 -83.74M -101.87M -68.24M -54.63M
    Selling & General & Admin
    		 23.39M 26.54M 20.15M 15.72M
    Research & Development
    		 65.74M 85.7M 51.01M 38.94M
    Other Expenses
    		 1.47M -70.9M -44.4M -1.51M
    Operating Expenses
    		 90.61M 41.34M 26.77M 53.15M
    Interest Expense
    		 1.59M 1.55M 1.19M 159K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 90.61M 118.42M 71.16M 54.66M
    Income Tax Expense
    		 n/a n/a -79K -1.35M
    Shares Outstanding (Basic)
    		 72.9M 72.55M 67.37M 52.76M
    Shares Outstanding (Diluted)
    		 72.9M 72.55M 67.37M 52.76M
    EPS (Basic)
    		 -1.15 -1.4 -1.01 -1.04
    EPS (Diluted)
    		 -1.15 -1.4 -1.01 -1.04
    EBITDA
    		 -81.1M -99.25M -66.11M -52.96M
    EBIT
    		 -82.14M -100.32M -67.13M -54.47M
    Depreciation & Amortization
    		 1.04M 1.07M 1.02M 1.51M

    Add to Watchlist